The need to identify effective therapies for the treatment of psychiatric disorders is a
particularly important issue in modern societies. In addition, difficulties in finding new drugs …

Background: Growing clinical interest in psychedelic-assisted therapies has led to a second
wave of research involving psilocybin, lysergic acid diethylamide (LSD), 3, 4 …

IntroductionPsychedelic-assisted therapy with psilocybin has shown promise in Phase 2
trials for alcohol use disorder (AUD). Set and setting, particularly factors facilitating a …

Alzheimer's Disease (AD) is a currently incurable but increasingly prevalent fatal and
progressive neurodegenerative disease, demanding consideration of therapeutically …

Eating disorders are serious illnesses showing high rates of mortality and comorbidity with
other mental health problems. Psychedelic-assisted therapy has recently shown potential in …

Abstract Purpose of Review This review article summarizes clinically and socially relevant
developments over the past five years in the therapeutic use of the classical tryptamine …

The rise of psychedelics in contemporary medicine has sparked interest in their potential
therapeutic applications. While traditionally associated with countercultural movements and …

With medical advancements promoting increased longevity, the number of older adults in
the population is rapidly growing. Correspondingly, the prevalence of older adults affected …

Abstract The phenylethylamine, 3, 4-methylenedioxymethamphetamine (MDMA,'ecstasy'), is
the prototypical example of an entactogen. Its original placement in highly restrictive drug …

There has been a resurgence of research into the therapeutic effects of psychedelic-assisted
therapies (PAT) within the last two decades, with groundbreaking results for some of the …